More recently, a dendrimer nano-radio-vehicle, containing lutetium-177 and encapsulated KRAS membrane association blocking molecule C19, was developed for a dual-targeted radio and chemotherapy in CXCR4+ pancreatic cancer cells [232]. Here, CXCR4 is linked to familial pancreatic carcinoma.